LLY vs. PG: Eli Lilly vs. Procter & Gamble Stock Comparison

November 11, 2026

How do Eli Lilly (LLY) and Procter & Gamble (PG) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Eli Lilly (LLY) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Procter & Gamble (PG) belongs to Consumer Staples (Household & Personal Products) — their GICS classifications point to very different parts of the market.

Company profile comparison for Eli Lilly (LLY) and Procter & Gamble (PG)
Profile Item	LLY	PG
Name	Eli Lilly and Company	The Procter & Gamble Company
Country/Region	United States	United States
GICS Sector	Health Care	Consumer Staples
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Household & Personal Products
GICS Industry	Pharmaceuticals	Household Products
GICS Sub-Industry	Pharmaceuticals	Household Products
Market Capitalization	1,206.07 billion USD	383.36 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	June 1, 1972	January 2, 1962
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

LLY

GSPC

Eli Lilly (LLY) vs. Procter & Gamble (PG), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Eli Lilly (LLY) and Procter & Gamble (PG). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Eli Lilly (LLY) and Procter & Gamble (PG). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Eli Lilly (LLY) and Procter & Gamble (PG)
Metric	LLY	PG
Total Return (1Y)	52.36%	17.45%
Total Return (3Y, Annualized)	34.18%	6.50%
Total Return (5Y, Annualized)	41.08%	5.59%

Risk Profile

Drawdown History

LLY

GSPC

Eli Lilly (LLY) vs. Procter & Gamble (PG), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Eli Lilly (LLY) and Procter & Gamble (PG). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Eli Lilly (LLY) and Procter & Gamble (PG)
Metric	LLY	PG
Volatility (1Y, Annualized)	35.34%	21.15%
Beta (5Y)	0.40	0.35
Max Drawdown (5Y)	-34.48%	-23.77%
Avg. Volume (3M)	2.52M	9.19M

Risk-Adjusted Performance

Risk-Return Positioning

LLY and PG are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Eli Lilly (LLY) and Procter & Gamble (PG)
Metric	LLY	PG
Sharpe Ratio (1Y)	1.36	0.62
Sortino Ratio (1Y)	2.29	0.96

Profitability

ROE (TTM)

Eli Lilly (LLY) at 86.02% sits in the top ROE quartile, while Procter & Gamble (PG) at 29.61% is closer to the peer norm — stronger capital efficiency for LLY.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

86.02%

Max: 109.18%
LLY: 86.02%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%

PG

Household & Personal Products industry group

29.61%

Max: 42.18%
Q3: 31.87%
PG: 29.61%
Median: 17.80%
Q1: 9.28%
Min: -14.64%

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their ROE against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Net Margin (TTM)

Eli Lilly (LLY) at 31.90% keeps the most of each sales dollar — above its industry’s net margin range — and Procter & Gamble (PG) at 18.23% also retains a top-quartile share.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

31.90%

LLY: 31.90%
Max: 18.05%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

PG

Household & Personal Products industry group

18.23%

Max: 23.47%
PG: 18.23%
Q3: 12.19%
Median: 8.50%
Q1: 3.08%
Min: -9.74%

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Operating Margin (TTM)

Procter & Gamble (PG) at 26.87% shows unusually strong operating efficiency — above its industry’s operating margin range — and Eli Lilly (LLY) at 53.66% also operates in the top quartile.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

53.66%

Max: 83.12%
LLY: 53.66%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

PG

Household & Personal Products industry group

26.87%

PG: 26.87%
Max: 23.94%
Q3: 17.03%
Median: 13.15%
Q1: 10.58%
Min: 1.87%

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Profitability Metrics

Profitability metrics for Eli Lilly (LLY) and Procter & Gamble (PG)
Metric	LLY	PG
ROE (TTM)	86.02%	29.61%
ROA (TTM)	21.06%	10.49%
Net Margin (TTM)	31.90%	18.23%
Operating Margin (TTM)	53.66%	26.87%
Gross Margin (TTM)	83.63%	50.59%

Growth

Revenue Growth

Procter & Gamble (PG) at 3.26% sits in the top revenue growth quartile, while Eli Lilly (LLY) at 44.70% is closer to the peer norm — faster top-line expansion for PG.

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their Revenue Growth across different time periods.

EPS Growth

Eli Lilly (LLY) at 95.99% sits in the top EPS growth quartile, while Procter & Gamble (PG) at 1.69% is closer to the peer norm — faster per-share earnings growth for LLY.

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Eli Lilly (LLY) and Procter & Gamble (PG)
Metric	LLY	PG
Revenue Growth (YoY)	44.70%	3.26%
Revenue Growth (3Y CAGR)	31.69%	2.00%
EPS Growth (YoY)	95.99%	1.69%
EPS Growth (3Y CAGR)	51.71%	3.91%

Financial Strength

Current Ratio (MRQ)

Both Eli Lilly (LLY) at 1.39 and Procter & Gamble (PG) at 0.72 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.39

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
LLY: 1.39
Min: 0.10

PG

Household & Personal Products industry group

0.72

Max: 4.26
Q3: 2.82
Median: 1.84
Q1: 0.92
PG: 0.72
Min: 0.65

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Debt / Equity (MRQ)

Procter & Gamble (PG) at 0.70 carries an industry-typical debt-to-equity mix, while Eli Lilly (LLY) at 1.23 uses more debt funding than most peers.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.23

Max: 1.42
LLY: 1.23
Q3: 0.65
Median: 0.15
Q1: 0.02
Min: 0.00

PG

Household & Personal Products industry group

0.70

Max: 2.30
Q3: 2.12
Median: 0.81
PG: 0.70
Q1: 0.50
Min: 0.01

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their debt-to-equity ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Financial Strength Metrics

Financial strength metrics for Eli Lilly (LLY) and Procter & Gamble (PG)
Metric	LLY	PG
Current Ratio (MRQ)	1.39	0.72
Debt / Equity (MRQ)	1.23	0.70
Net Debt / EBITDA	0.96	0.94

Dividends

Dividend Yield (TTM)

Procter & Gamble (PG) at 2.57% earns its spot in the top quartile of its industry’s yields; Eli Lilly (LLY) at 0.49% is past the top of its own peer range — territory where a dividend-safety check matters more than the headline number.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.49%

LLY: 0.49%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PG

Household & Personal Products industry group

2.57%

Max: 5.00%
PG: 2.57%
Q3: 2.47%
Median: 1.30%
Q1: 0.00%
Min: 0.00%

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Dividend Payout Ratio (TTM)

Procter & Gamble (PG) at 64.62% keeps its payout in the industry’s typical band, while Eli Lilly (LLY) at 21.71% pays out more than any of its peers — the most stretched cover in its group.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

21.71%

LLY: 21.71%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PG

Household & Personal Products industry group

64.62%

Max: 140.00%
Q3: 73.75%
PG: 64.62%
Median: 46.43%
Q1: 0.00%
Min: 0.00%

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Dividend Metrics

Dividend metrics for Eli Lilly (LLY) and Procter & Gamble (PG)
Metric	LLY	PG
Dividend Yield (TTM)	0.49%	2.57%
Dividend Payout Ratio (TTM)	21.71%	64.62%

Valuation

P/E Ratio (TTM)

Procter & Gamble (PG) at 24.91 is near its industry’s usual P/E ratio, while Eli Lilly (LLY) at 43.95 sits in the richer quartile — LLY needs stronger growth or earnings quality to justify the premium.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

43.95

Max: 85.34
LLY: 43.95
Q3: 43.46
Median: 26.69
Q1: 13.30
Min: 0.07

PG

Household & Personal Products industry group

24.91

Max: 37.57
Q3: 33.54
PG: 24.91
Median: 20.03
Q1: 15.76
Min: 6.45

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

P/S Ratio (TTM)

Eli Lilly (LLY) at 13.95 is priced about in line with its industry on P/S ratio, while Procter & Gamble (PG) at 4.36 sits in the pricier quartile — PG costs more per dollar of sales.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.95

Max: 58.18
Q3: 25.77
LLY: 13.95
Median: 7.30
Q1: 3.01
Min: 0.01

PG

Household & Personal Products industry group

4.36

PG: 4.36
Max: 4.36
Q3: 3.57
Median: 1.68
Q1: 0.76
Min: 0.30

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

P/B Ratio (MRQ)

Procter & Gamble (PG) at 7.05 sits near its industry’s typical P/B ratio, while Eli Lilly (LLY) at 29.96 prices above its benchmark range — LLY looks rich relative to book.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

29.96

LLY: 29.96
Max: 13.53
Q3: 6.54
Median: 3.25
Q1: 1.69
Min: -5.59

PG

Household & Personal Products industry group

7.05

Max: 12.30
Q3: 7.43
PG: 7.05
Median: 3.44
Q1: 1.30
Min: -3.91

Eli Lilly (LLY) vs. Procter & Gamble (PG): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Valuation Metrics

Valuation metrics for Eli Lilly (LLY) and Procter & Gamble (PG)
Metric	LLY	PG
P/E Ratio (TTM)	43.95	24.91
P/S Ratio (TTM)	13.95	4.36
P/B Ratio (MRQ)	29.96	7.05
Free Cash Flow Yield (TTM)	0.77%	3.30%